The Mississippi Society of Oncology was formed in 1991 for the purpose ofpromoting the highest professional standards of oncology in Mississippi, to study, research and exchange information, experiences and ideas leading to improvement in oncology and promote educational opportunities.
In addition, the MOS is committed to support the search for more effective treatments of malignant diseases, work with other organizations and societies that have concerns with cancer care, and disseminate information regarding regulatory developments affecting members.
And finally the MOS acts as a resource for insurers regarding the standard of care in oncology and represents the practice of oncology and hematology in the State of Mississippi.
No one should have to fight Cancer alone. Join Amgen and six independent non-profit organizations that span the continuum of cancer care. The information and resources within these pages has been provided by the Breakaway from Cancer partners. Amgen has no control over these programs and provides information as a courtesy only.
For Some Cancer Patients, Monitoring Symptoms Can Extend Their Lives A growing body of research has found that people with cancer who are routinely prompted to answer questions about their symptoms may live months longer and have a higher quality of life than people who don’t track their symptoms as closely.
American Cancer Society Announces New Video Series Created to Deliver Clinical and Emotional Support to Cancer Caregivers To help support cancer caregivers, the American Cancer Society (ACS) has created a Caregiver Support Video Series that can answer caregivers' most-asked questions and address their biggest concerns.
Community Needs More Time to Assess and Comment on CMMI’s Proposed Oncology Care First Model Recently the Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (CMMI) released an informal request for information for a new model for value-based payments in oncology known as the “Oncology Care First” (OCF) model. However, oncology practices and stakeholders need more time to adequately assess and provide detailed feedback on the OCF than the time CMMI has allotted.
ASCO to Launch Association for Clinical Oncology in January 2020 TheAmerican Society of Clinical OncologyislaunchingtheAssociation for ClinicalOncology, a501(c)(6) professional association,that will enableexpanded advocacyactivities and increase the impact of efforts directed toward policymakers in support of high-qualitypatient care.
Patients Need Protection From Surprise Medical Bills, Organizations Tell Congress
In a letter to leaders of the U.S. Senate and House of Representatives, ASCO, along with more than 100 other medical groups, urged Congress to protect patients from unanticipated, or “surprise,” medical bills that can occur when gaps in health insurance coverage lead them to receive care from out-of-network providers.
Could Biosimilars Be Integrated into Alternative Payment Models? Michael Kolodziej, MD, Vice President and Chief Innovation Officer at ADVI Health, Inc, addresses the role that biosimilars will have in alternative payment models in oncology.
Cancer Pain Predicted by Lower Anxiety and Depression, Higher Social Support A new study from the Levine Cancer Institute finds that patients with cancer who report higher levels of anxiety and depression experience more intense pain associated with their diseases.
Nearly 60% of Blood Cancer Patients Covered by Medicare Delay or Forgo Treatment Survival of older patients with blood cancers continues to improve as more effective, less toxic therapies are introduced. However, these lifesaving treatments often are expensive and many cancer patients face financial burdens caused by ever-increasing healthcare costs. In fact, according to a new study released October 21st by The Leukemia & Lymphoma Society (LLS), 59 percent of surviving blood cancer patients enrolled in traditional Medicare do not begin active treatment within three months of their diagnosis.
New ASCO Policy Brief: How Co-Pay Accumulators and Co-pay Maximizers Increase Cost of Cancer Care for Patients Co-pay accumulators and co-pay maximizers have been an area of concern amongst State Affiliate Council members. ASCO has created a new informational policy brief to help explain these programs and provide guidance regarding its position as an organization. The brief can be accessed by clicking below.
Report: Progress in Global Cancer Fight is Not Only Possible, but Achievable The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.
United Health and Optum 'Uniting Care and Coverage' in New Model UnitedHealth Group and its Optum medical care provider business are rolling out a combined package of medical care and health insurance as they meld health benefits with the provision of healthcare services.
New Survey Seeks Provider Input on Clinical Trial Enrollment ASCO is participating in a joint initiative from the American Cancer Society's Cancer Action Network in conjunction with the Association of Community Cancer Centers and the Oncology Nursing Society. Click below to access the survey.
Walmart to Measure Doctor Quality in Local Markets Walmart is rolling out an effort to measure the quality of community doctors who treat tens of thousands of its employees in the retailer’s latest effort to make sure its workers get the right care, in the right place and at the right time.
CMS to Collect 340B Drug Cost Information The CMS issued a notice on September 26th that it will collect information from hospitals participating in the 340B drug discount program about the prices they pay for eligible drugs.
Cancer Drugs Account for 27% of All New Drug Approvals in the US
Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010, a dramatic increase from the 4% share of the 1980s, a newly completed analysis from the Tufts Center for the Study of Drug Development shows.
Educate and Support Your Patients with ASCO Answers Materials
Recently, State Affiliate presidents and executive directors received a mailing from Cancer.Net that included patient education materials that you and your members may find useful. These materials, along with additional resources that can be found on Cancer.Net give your patients ASCO-approved information on diagnosis, treatment, side effects, and psychosocial effects of cancer. The ASCO Answers series includes fact sheets, booklets on specific topics in cancer care, and comprehensive, patient-friendly guides. These easy-to-read materials cover breast cancer, colorectal cancer, non-small cell lung cancer, small cell lung cancer, prostate cancer, cancer survivorship, caregiving, palliative care, managing cancer-related pain, advanced cancer care planning, and much more. ASCO members save 20 percent. All orders include free domestic shipping.
Improving Seniors’ Timely Access to Care Act of 2019
The Mississippi Society of Oncology is proud to have joined with hundreds of other health organizations to support the Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107) recently introduced by Reps. Suzan DelBene (D-WA), Mike Kelly (R-PA), Roger Marshall, MD (R-KS), and Ami Bera, MD (D-CA).